Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yukari Tsubata

Showing results (51-60 of 121) with videos related to

Pageof 13
Sort By:
Anticancer Research|May 6, 2021
ERCC1 Is a Predictive Biomarker for Non-small Cell Lung Cancer But Is Antibody-dependentTamio Okimoto, Yukari Tsubata, Ryosuke Tanino, et al.
Scientific Reports|October 5, 2017
Evaluation of the heterogeneous tissue distribution of erlotinib in lung cancer using matrix-assisted laser desorption ionization mass spectrometry imagingYukari Tsubata, Mitsuhiro Hayashi, Ryosuke Tanino, et al.
Japanese Journal of Clinical Oncology|May 21, 2024
D-dimer cut-off value for predicting venous thromboembolism at the initial diagnosis in Japanese patients with advanced lung cancerKeita Kawakado, Yukari Tsubata, Takamasa Hotta, et al.
Respiratory Investigation|February 28, 2020
Comparison of the chest computed tomography findings between patients with pulmonary tuberculosis and those with Mycobacterium avium complex lung diseaseKiyotaka Miura, Megumi Nakamura, Yasuyuki Taooka, et al.
Thoracic Cancer|March 20, 2023
Immune-related adverse events in hepatitis treated with thiopurine-based immunosuppressants: A case reportKeita Kawakado, Kazuhisa Nakashima, Hiroshi Tobita, et al.
Cancer Medicine|January 9, 2025
Arterial Thromboembolism in Patients With Advanced Lung Cancer: Secondary Analyses of the Rising-VTE/NEJ037 StudyNaoki Furuya, Yukari Tsubata, Takamasa Hotta, et al.
Internal Medicine (Tokyo, Japan)|December 17, 2023
Cytokine Release Syndrome More than Two Years after Pembrolizumab IntroductionKazuhisa Nakashima, Kashu Kitani, Kento Kono, et al.
Respirology Case Reports|April 13, 2023
An 83-year-old patient with RET fusion-positive non-small cell lung cancer experiencing severe hepatic disorder due to selpercatinib administrationKazuhisa Nakashima, Yuki Mitarai, Seiko Tanaka, et al.
International Journal of Chronic Obstructive Pulmonary Disease|May 4, 2026
A Predicted FEV1/FVC Model Based on a Simple Respiratory Questionnaire for Early Diagnosis of COPD in Shimane Cohort, JapanMika Nakao, Tamio Okimoto, Akari Tanino, et al.
Case Reports in Oncology|May 9, 2022
Acute Exacerbation of Tracheal Obstruction and Severe Respiratory Failure after a Single Dose of 2-Gy Irradiation for Squamous Cell Lung Carcinoma: A Case ReportKeita Kawakado, Takamasa Hotta, Jin Sakamoto, et al.
Pageof 13

Showing results (51-60 of 121) with videos related to

Sort By:
Pageof 13
Anticancer Research|May 6, 2021
ERCC1 Is a Predictive Biomarker for Non-small Cell Lung Cancer But Is Antibody-dependentTamio Okimoto, Yukari Tsubata, Ryosuke Tanino, et al.
Scientific Reports|October 5, 2017
Evaluation of the heterogeneous tissue distribution of erlotinib in lung cancer using matrix-assisted laser desorption ionization mass spectrometry imagingYukari Tsubata, Mitsuhiro Hayashi, Ryosuke Tanino, et al.
Japanese Journal of Clinical Oncology|May 21, 2024
D-dimer cut-off value for predicting venous thromboembolism at the initial diagnosis in Japanese patients with advanced lung cancerKeita Kawakado, Yukari Tsubata, Takamasa Hotta, et al.
Respiratory Investigation|February 28, 2020
Comparison of the chest computed tomography findings between patients with pulmonary tuberculosis and those with Mycobacterium avium complex lung diseaseKiyotaka Miura, Megumi Nakamura, Yasuyuki Taooka, et al.
Thoracic Cancer|March 20, 2023
Immune-related adverse events in hepatitis treated with thiopurine-based immunosuppressants: A case reportKeita Kawakado, Kazuhisa Nakashima, Hiroshi Tobita, et al.
Cancer Medicine|January 9, 2025
Arterial Thromboembolism in Patients With Advanced Lung Cancer: Secondary Analyses of the Rising-VTE/NEJ037 StudyNaoki Furuya, Yukari Tsubata, Takamasa Hotta, et al.
Internal Medicine (Tokyo, Japan)|December 17, 2023
Cytokine Release Syndrome More than Two Years after Pembrolizumab IntroductionKazuhisa Nakashima, Kashu Kitani, Kento Kono, et al.
Respirology Case Reports|April 13, 2023
An 83-year-old patient with RET fusion-positive non-small cell lung cancer experiencing severe hepatic disorder due to selpercatinib administrationKazuhisa Nakashima, Yuki Mitarai, Seiko Tanaka, et al.
International Journal of Chronic Obstructive Pulmonary Disease|May 4, 2026
A Predicted FEV1/FVC Model Based on a Simple Respiratory Questionnaire for Early Diagnosis of COPD in Shimane Cohort, JapanMika Nakao, Tamio Okimoto, Akari Tanino, et al.
Case Reports in Oncology|May 9, 2022
Acute Exacerbation of Tracheal Obstruction and Severe Respiratory Failure after a Single Dose of 2-Gy Irradiation for Squamous Cell Lung Carcinoma: A Case ReportKeita Kawakado, Takamasa Hotta, Jin Sakamoto, et al.
Pageof 13